Full-Time

Clinical Services Manager

Confirmed live in the last 24 hours

Insulet Corporation

Insulet Corporation

1,001-5,000 employees

Develops tubeless insulin delivery systems

No salary listed

Senior

Lichtenfels, Germany + 4 more

More locations: Jena, Germany | Cottbus, Germany | Germany | Dresden, Germany

This position requires on-site work (travel required in assigned territory).

Category
Nursing & Allied Health Professionals
Medical, Clinical & Veterinary
Required Skills
Salesforce
Connection
Connection
Connection
logo

Get referrals →

You have ways to get a Insulet Corporation referral from your network.

💡

Applications through a referral are 3x more likely to get an interview!

Requirements
  • Professional presentation skills
  • Strong interpersonal communication, both verbal and written
  • Teamwork, commitment, and self-responsibility
  • Independent and flexible working style, combined with good business acumen
  • Credibility and contacts within the diabetes community
  • Basic computer skills
  • Fluent in German, both spoken and written
  • Valid driving license required
Responsibilities
  • Organizing and independently conducting training sessions with clinics and practices
  • Communicating the benefits of insulin pump therapy and training on the Omnipod® system in group and individual sessions
  • Working closely with Sales, Medical, Marketing, Customer Care, and Market Access to achieve sales targets
  • Assisting and guiding in the prescription process of the Omnipod® system
  • Participating in and supporting diabetes congresses, patient group meetings, informational events, patient days, and training sessions
  • Assisting in the support of development and existing customers and documenting work in the CRM system Salesforce
  • Regularly conducting product demonstrations for patients and healthcare professionals
  • Supporting new employees with product training
  • Planning and conducting training sessions for diabetes advisors, freelancers, and intermediaries
  • Providing feedback on market conditions and training to supervisors
  • Timely completion of administrative tasks
  • Performing other assigned tasks
Desired Qualifications
  • Proven experience in training and/or treating pump patients or equivalent education and experience
  • Diabetes Advisor DDG is preferred
  • Previous industry experience is desirable
  • Certified nutritionist is an advantage
  • Excellent communication skills, both written and verbal
  • Experience in dealing directly with healthcare professionals and diabetes patients

Insulet Corporation develops medical devices aimed at simplifying life for people with diabetes. Their main product, the Omnipod Insulin Management System, is a tubeless device that delivers insulin continuously for up to three days without needles. The Omnipod 5 Automated Insulin Delivery System integrates with a continuous glucose monitor, allowing users to manage blood sugar without multiple injections or fingersticks. Insulet differentiates itself by providing a user-friendly solution that enhances insulin management, with the goal of improving the quality of life for individuals with diabetes.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Acton, Massachusetts

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing demand for advanced diabetes solutions expands Insulet's market opportunities.
  • Omnipod 5's European expansion increases Insulet's international market presence.
  • Advancements in sensor technology enhance the reliability of Insulet's Omnipod system.

What critics are saying

  • Leadership transition to Ashley McEvoy may lead to strategic instability.
  • Increased competition from DexCom and Tandem Diabetes Care challenges Insulet's market share.
  • Potential financial strain from $450M senior notes offering could impact cash flow.

What makes Insulet Corporation unique

  • Insulet's Omnipod 5 integrates with Dexcom G7 CGM, enhancing diabetes management.
  • The RADIANT trial showcases Insulet's innovation in transitioning from daily injections to Omnipod.
  • Insulet's $452M trade secret victory strengthens its competitive position in insulin pump technology.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
RTTNews
Apr 28th, 2025
Insulet CEO Jim Hollingshead Resigns, Ashley McEvoy To Succeed; Raises Q1 Guidance

Insulet Corp. (PODD), a medical device company, on Monday announced that Chief Executive Officer Jim Hollingshead has resigned from the Board of Directors.

MD+DI
Apr 28th, 2025
Insulet Names Ex-J&J MedTech Chief Ashley McEvoy as CEO

Ashley McEvoy has been tapped to be president and CEO of Insulet.

Financial Modeling Prep
Mar 28th, 2025
Insulet Corporation's Financial Efficiency in the Medical Device Industry

Insulet competes with companies like DexCom, Tandem Diabetes Care, and Masimo Corporation in the diabetes care market.

Stock Titan
Mar 18th, 2025
Insulet Secures $450M Through Senior Notes Offering: Key Details on Strategic Debt Refinancing

Insulet raises $444.4M through senior notes to refinance existing convertible debt. Strategic move positions medical device maker for future growth while optimizing capital structure.

Stock Titan
Mar 18th, 2025
From Injections to Innovation - Insulet to Present Results from a Multinational Randomized Trial of Direct Transition from Multiple Daily Injections to Omnipod(R) 5 in Adults and Children with Type 1 Diabetes

Insulet (NASDAQ: PODD) will present results from its multinational RADIANT trial at the 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in March 2025.